Literature DB >> 11891642

A converging-methods approach to fragile X syndrome.

James D Churchill1, Aaron W Grossman, Scott A Irwin, Roberto Galvez, Anna Y Klintsova, Ivan Jeanne Weiler, William T Greenough.   

Abstract

Converging approaches across domains of brain anatomy, cell biology, and behavior indicate that Fragile X syndrome, arising from impaired expression of a single gene and protein, appears to involve an aberration of normal developmental processes. Synapse overproduction and selective elimination, or pruning, characterize normal brain development. In autopsy tissue from Fragile X patients and in a knockout mouse model of the disease, synapse overproduction appears to occur unaccompanied by synapse pruning and maturation, leaving an excess of immature spine synapses in place. The absence of the Fragile X protein seems to impair the synthesis of important proteins at synapses. The developmental outcome in Fragile X is a nervous system that is relatively disorganized, resulting in disrupted perceptual, and cognitive social, behavior. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11891642     DOI: 10.1002/dev.10036

Source DB:  PubMed          Journal:  Dev Psychobiol        ISSN: 0012-1630            Impact factor:   3.038


  12 in total

1.  Effects of X-monosomy and X-linked imprinting on superior temporal gyrus morphology in Turner syndrome.

Authors:  Shelli R Kesler; Christine M Blasey; Wendy E Brown; Jerome Yankowitz; She Min Zeng; Bruce G Bender; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2003-09-15       Impact factor: 13.382

2.  Developmental characteristics of dendritic spines in the dentate gyrus of Fmr1 knockout mice.

Authors:  Aaron W Grossman; Georgina M Aldridge; Kea Joo Lee; Michelle K Zeman; Christine S Jun; Humza S Azam; Tatsuo Arii; Keiji Imoto; William T Greenough; Im Joo Rhyu
Journal:  Brain Res       Date:  2010-08-02       Impact factor: 3.252

Review 3.  Neurodevelopment of children with single suture craniosynostosis: a review.

Authors:  Kathleen A Kapp-Simon; Matthew L Speltz; Michael L Cunningham; Pravin K Patel; Tadanori Tomita
Journal:  Childs Nerv Syst       Date:  2006-12-21       Impact factor: 1.475

4.  The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndrome.

Authors:  Samantha Portis; Brian Giunta; Demian Obregon; Jun Tan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20

5.  Phonological accuracy and intelligibility in connected speech of boys with fragile X syndrome or Down syndrome.

Authors:  Elizabeth Barnes; Joanne Roberts; Steven H Long; Gary E Martin; Mary C Berni; Kerry C Mandulak; John Sideris
Journal:  J Speech Lang Hear Res       Date:  2009-08       Impact factor: 2.297

Review 6.  New insights in the biology of BDNF synthesis and release: implications in CNS function.

Authors:  Michael E Greenberg; Baoji Xu; Bai Lu; Barbara L Hempstead
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

7.  Control of spine maturation and pruning through proBDNF synthesized and released in dendrites.

Authors:  Lauren L Orefice; Chien-Cheng Shih; Haifei Xu; Emily G Waterhouse; Baoji Xu
Journal:  Mol Cell Neurosci       Date:  2015-12-17       Impact factor: 4.314

8.  Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines.

Authors:  Lauren L Orefice; Emily G Waterhouse; John G Partridge; Rupa R Lalchandani; Stefano Vicini; Baoji Xu
Journal:  J Neurosci       Date:  2013-07-10       Impact factor: 6.167

Review 9.  Sensory Processing Phenotypes in Fragile X Syndrome.

Authors:  Maham Rais; Devin K Binder; Khaleel A Razak; Iryna M Ethell
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

10.  The effects of early-life immune activation on microglia-mediated neuronal remodeling and the associated ontogeny of hippocampal-dependent learning in juvenile rats.

Authors:  Brittany F Osborne; Sarah B Beamish; Jaclyn M Schwarz
Journal:  Brain Behav Immun       Date:  2021-06-11       Impact factor: 19.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.